General MedicationsORALGeneric
SIPONIMOD
SIPONIMOD
Standard Dose
1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview SIPONIMOD is listed in Drugs@FDA under application 218228 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SIPONIMOD Form and strength TABLET;ORAL - 1MG Sponsor CIPLA LTD Submission history Latest submission status date: 2025-01-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview SIPONIMOD is listed in Drugs@FDA under application 218228 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient SIPONIMOD Form and strength TABLET;ORAL - 1MG Sponsor CIPLA LTD Submission history Latest submission status date: 2025-01-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.